Krishnan Viswanadhan's most recent trade in CARGO Therapeutics Inc was a trade of 25,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CARGO Therapeutics Inc | Krishnan Viswanadhan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Agios Pharmaceuticals Inc | Krishnan Viswanadhan | Chief Corp Dev & Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 55,374 | 55,374 | - | - | Stock options (right to buy) | |
| Agios Pharmaceuticals Inc | Krishnan Viswanadhan | Chief Corp Dev & Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 24,300 | 24,300 | - | - | Restricted stock units | |
| CARGO Therapeutics Inc | Krishnan Viswanadhan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 23,742 | 23,742 | - | - | Stock Option (Right to Buy) |